Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
Authors
Keywords
CDH17, SPINK1, CDH17/β-catenin axis, HCC
Journal
CELLULAR ONCOLOGY
Volume 40, Issue 5, Pages 443-456
Publisher
Springer Nature
Online
2017-06-19
DOI
10.1007/s13402-017-0332-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway
- (2016) Junshan Liu et al. CELLULAR ONCOLOGY
- NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy
- (2016) Vignesh Ramesh et al. CELLULAR ONCOLOGY
- Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC)
- (2015) Weijin Xu et al. MEDICAL ONCOLOGY
- TATI as a biomarker
- (2014) Outi Itkonen et al. CLINICA CHIMICA ACTA
- Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2
- (2014) Felice H. Tsang et al. DIGESTIVE DISEASES AND SCIENCES
- Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer
- (2014) Chunni Wang et al. PROSTATE
- Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells
- (2014) Victor Au et al. BioScience Trends
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
- (2013) Z. Kan et al. GENOME RESEARCH
- Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
- (2013) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Involvement of liver-intestine cadherin in cancer progression
- (2013) Masaaki Takamura et al. Medical Molecular Morphology
- Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis
- (2013) R A Bartolomé et al. ONCOGENE
- Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling
- (2013) Hai-bo Qiu et al. PLoS One
- Global Gene Expression Profiling Reveals SPINK1 as a Potential Hepatocellular Carcinoma Marker
- (2013) Aileen Marshall et al. PLoS One
- Anti-Cadherin-17 Antibody Modulates Beta-Catenin Signaling and Tumorigenicity of Hepatocellular Carcinoma
- (2013) Yonggang Wang et al. PLoS One
- Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma
- (2013) Ilana Lyytinen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
- (2012) Wing-Kin Sung et al. NATURE GENETICS
- Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma
- (2012) S Fatima et al. ONCOGENE
- Gene Signatures Derived from a c-MET-Driven Liver Cancer Mouse Model Predict Survival of Patients with Hepatocellular Carcinoma
- (2011) Irena Ivanovska et al. PLoS One
- Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting
- (2011) John R. Lamb et al. PLoS One
- Therapeutic Targeting of SPINK1-Positive Prostate Cancer
- (2011) B. Ateeq et al. Science Translational Medicine
- Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer
- (2010) Helena R. Chang CANCER
- HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma
- (2010) Rui Zhu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma
- (2009) Zhen-Bin Ding et al. CANCER
- Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma
- (2009) Ling Xiao Liu et al. HEPATOLOGY
- Serine Protease Inhibitor Kazal Type 1 Promotes Proliferation of Pancreatic Cancer Cells through the Epidermal Growth Factor Receptor
- (2009) N. Ozaki et al. MOLECULAR CANCER RESEARCH
- Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene
- (2008) Benjamin Cieply et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More